Also trades as: ZLD.AX (ASX) · $vol 0M
ZLDAF OTC
Zelira Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: -25.7%
YTD: -4.3%
1Y: -1.4%
3Y: -52.7%
5Y: -96.1%
$0.26
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$5M
-11.8% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$5M
-11.8% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$580K
-196.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$9M | -$12M | -$6M | -$37M | -$4M |
| Depreciation & Amort. | $474K | $589K | $545K | $0 | $270K |
| Stock-Based Comp. | $1M | $3M | $405K | $0 | -$1M |
| Change in Working Capital | -$558K | -$685K | $863K | $2M | $0 |
| Other Non-Cash Items | $2M | $4M | -$3M | $30M | -$362K |
| Operating Cash Flow | -$9M | -$9M | -$7M | -$4M | -$5M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $736K | $0 | $0 |
| Other Investing | $1M | -$208K | $2M | $920K | $1M |
| Investing Cash Flow | $1M | -$208K | $3M | $920K | $1M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $4M | $2M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $1M |
| Financing Cash Flow | $11M | $7M | $2M | $4M | $3M |
| Net Change in Cash | $3M | -$2M | -$3M | $601K | -$580K |
| Cash End of Period | $5M | $3M | $146K | $586K | $6K |
| Free Cash Flow | -$9M | -$9M | -$7M | -$4M | -$5M |